Maxwell Biosciences Selected to Receive a Nearly $3M Award from Medical Technology Enterprise Consortium (MTEC) #antimicrobialresistance #biotech #governmentawards #immunesystem #MTEC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals
Austin, Texas--(Newsfile Corp. - October 24, 2024) - Maxwell Biosciences is developing a new type of anti-infective drug designed to improve upon natural immune system peptides. The company announced today it has been selected to receive a nearly $3M award from the Medical Technology Enterprise Consortium (MTEC). MTEC works in cooperation with the U.S. Army Medical Research and Development Command (USAMRDC) and the U.S. Department of Defense. Maxwell received this award for its proposal titled...
http://dlvr.it/TFhMqx
http://dlvr.it/TFhMqx
Comments
Post a Comment